Search

Search Constraints

You searched for: Author/Creator Gandy, Sam

Search Results

3. Alzheimer's disease research and development: a call for a new research roadmap. (April 2014)

5. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy. (16th February 2023)

6. BCI‐838, an orally active mGluR2/3 antagonist pro‐drug, mimics the beneficial effects of physical exercise on neurogenesis, behavior and exercise‐related molecular pathways in an Alzheimer's disease mouse model. (20th December 2022)

8. Decrease in p3‐Alcβ37 and p3‐Alcβ40, products of Alcadein β generated by γ‐secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Issue 1 (1st January 2019)

9. Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model. Issue 10 (1st July 2014)

10. Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes. Issue 3 (June 2016)